Mikrogen
Private Company
Funding information not available
Overview
Mikrogen is an established, privately-held German diagnostics company with over 30 years of experience, recognized as a market leader in infectious serology. It has built a comprehensive portfolio of automated platforms for chemiluminescence immunoassays (CLIA) and PCR-based molecular diagnostics, serving clinical laboratories worldwide. The company is IVDR certified, underscoring its regulatory compliance in the European market. Its strategy centers on continuous innovation in automation and assay development to address complex infectious diseases.
Technology Platform
Portfolio of automated diagnostic platforms including KleeYa (chemiluminescence immunoassay - CLIA) and ampli Cube (fully automated PCR for molecular diagnostics), supported by Mic qPCR cycler and Ca r L processing automation.
Opportunities
Risk Factors
Competitive Landscape
Mikrogen competes in the infectious disease serology and molecular diagnostics segment against major players like DiaSorin, Euroimmun (PerkinElmer), and Siemens Healthineers, as well as larger broad-based IVD companies like Roche and Abbott. Its differentiation lies in its specialized focus on recombinant antigen-based serology, full automation solutions, and IVDR-certified status.